Valproic acid

Generic Name
Valproic acid
Brand Names
Depakene, Depakote, Epival
Drug Type
Small Molecule
Chemical Formula
C8H16O2
CAS Number
99-66-1
Unique Ingredient Identifier
614OI1Z5WI
Background

Valproic acid, or valproate, is an fatty acid derivative and anticonvulsant originally synthesized in 1881 by Beverly S. Burton. It enjoyed use as a popular organic solvent in industry and pharmaceutical manufacturing for nearly a century. In 1963, a serendipitous discovery was made by George Carraz during his investigations into the anticonvulsant effects o...

Indication

Indicated for:

1) Use as monotherapy or adjunctive therapy in the management of complex partial seizures and simple or complex absence seizures.

2) Adjunctive therapy in the management of multiple seizure types that include absence seizures.

3) Prophylaxis of migraine headaches.

4) Acute management of mania associated with bipolar disorder.
...

Associated Conditions
Bipolar Disorder (BD), Complex Partial Seizure Disorder, Depressive Episodes, Migraine, Petit Mal Epilepsy, Seizure, multiple types, Acute Manic episode
Associated Therapies
-

Decision-Making in Bipolar Disorder

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2011-11-01
Last Posted Date
2017-05-31
Lead Sponsor
Emory University
Target Recruit Count
37
Registration Number
NCT01463111
Locations
🇺🇸

Emory University Mood and Anxiety Disorders Program, Atlanta, Georgia, United States

Efficacy and Safety of Oral Valproic Acid for Retinitis Pigmentosa

First Posted Date
2011-07-21
Last Posted Date
2016-04-14
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
200
Registration Number
NCT01399515
Locations
🇰🇷

Department of Ophthalmology, Seoul National University Hospital, Seoul, Korea, Republic of

Treatment Strategy for Alcohol Use Disorders in Veterans With TBI

Phase 3
Completed
Conditions
Interventions
First Posted Date
2011-04-27
Last Posted Date
2016-06-09
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
62
Registration Number
NCT01342549
Locations
🇺🇸

Iowa City VA Health Care System, Iowa City, IA, Iowa City, Iowa, United States

🇺🇸

Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States

Valproic Acid With Chemoradiotherapy for Pancreatic Cancer

Phase 2
Conditions
Interventions
First Posted Date
2011-04-12
Last Posted Date
2011-04-12
Lead Sponsor
Soroka University Medical Center
Target Recruit Count
20
Registration Number
NCT01333631

Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures

Conditions
Interventions
First Posted Date
2010-12-31
Last Posted Date
2010-12-31
Lead Sponsor
Hillel Yaffe Medical Center
Target Recruit Count
50
Registration Number
NCT01268904
Locations
🇮🇱

Hillel Yaffe Medical Center, Hadera, Israel

Valproate Versus Ketorolac Versus Metoclopramide

First Posted Date
2010-12-29
Last Posted Date
2018-06-04
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
330
Registration Number
NCT01267864
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Trial of Oral Valproic Acid for Retinitis Pigmentosa

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-11-03
Last Posted Date
2017-12-02
Lead Sponsor
Foundation Fighting Blindness
Target Recruit Count
90
Registration Number
NCT01233609
Locations
🇺🇸

University of Utah School of Medicine, Moran Eye Center, Salt Lake City, Utah, United States

🇺🇸

University of Tennessee, Hamilton Eye Institute, Memphis, Tennessee, United States

🇺🇸

Retina Foundation of the Southwest, Dallas, Texas, United States

and more 3 locations

Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma

First Posted Date
2010-09-17
Last Posted Date
2016-12-23
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Target Recruit Count
7
Registration Number
NCT01204450
Locations
🇺🇸

Carolina Healthcare System, Charlotte, North Carolina, United States

🇺🇸

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer

First Posted Date
2010-09-16
Last Posted Date
2011-03-29
Lead Sponsor
Soroka University Medical Center
Target Recruit Count
20
Registration Number
NCT01203735
Locations
🇮🇱

Soroka University Medical Center, Beer Sheva, Israel

Add-on Dextromethorphan in Bipolar Disorders

First Posted Date
2010-08-25
Last Posted Date
2013-09-17
Lead Sponsor
National Cheng-Kung University Hospital
Target Recruit Count
300
Registration Number
NCT01188265
Locations
🇨🇳

Ru-Band Lu, Tainan, Taiwan

© Copyright 2024. All Rights Reserved by MedPath